Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma

In adults, pilocytic astrocytomas (PA) account for less than 2% of gliomas, resulting in uncertainty regarding the clinical course and optimal treatment, particularly in cases where gross total resection (GTR) could not be achieved. Moreover, information on molecular markers and their prognostic imp...

Full description

Saved in:
Bibliographic Details
Main Authors: Jungk, Christine (Author) , Reinhardt, Annekathrin (Author) , Warta, Rolf (Author) , Capper, David (Author) , Deimling, Andreas von (Author) , Herold-Mende, Christel (Author) , Unterberg, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 29 July 2019
In: Cancers
Year: 2019, Volume: 11, Issue: 8
ISSN:2072-6694
DOI:10.3390/cancers11081072
Online Access:Verlag, Volltext: https://doi.org/10.3390/cancers11081072
Verlag: https://www.mdpi.com/2072-6694/11/8/1072
Get full text
Author Notes:Christine Jungk, Annekathrin Reinhardt, Rolf Warta, David Capper, Andreas von Deimling, Christel Herold-Mende and Andreas Unterberg

MARC

LEADER 00000caa a2200000 c 4500
001 1679171925
003 DE-627
005 20210817011354.0
007 cr uuu---uuuuu
008 191021s2019 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers11081072  |2 doi 
035 |a (DE-627)1679171925 
035 |a (DE-599)KXP1679171925 
035 |a (OCoLC)1264105847 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jungk, Christine  |e VerfasserIn  |0 (DE-588)1051888247  |0 (DE-627)78696765X  |0 (DE-576)407515968  |4 aut 
245 1 0 |a Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma  |c Christine Jungk, Annekathrin Reinhardt, Rolf Warta, David Capper, Andreas von Deimling, Christel Herold-Mende and Andreas Unterberg 
264 1 |c 29 July 2019 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.10.2019 
520 |a In adults, pilocytic astrocytomas (PA) account for less than 2% of gliomas, resulting in uncertainty regarding the clinical course and optimal treatment, particularly in cases where gross total resection (GTR) could not be achieved. Moreover, information on molecular markers and their prognostic impact is sparse. In order to improve risk stratification, we analyzed our institutional series of 58 patients aged 17 years and older with histology-proven intracranial PA World Health Organization grade I for clinical and molecular prognosticators. Anaplastic and NF1-associated tumors were excluded. O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status was determined by pyrosequencing or 450k/850k DNA methylation array. A univariate log-rank test and multivariate StepAIC were applied to identify prognostic factors. The median age was 30 years (range 17&ndash;66). Tumors were located in the cerebral/cerebellar hemispheres, midline structures and cerebello-pontine angle in 53%, 38% and 9%. MGMT promoter methylation was present in eight patients (14%). GTR (39/58 patients) significantly reduced the likelihood of tumor recurrence (p = 0.0001). Tumor relapse occurred in 16 patients (28%) after a median progression-free survival (PFS) of 135 months (range 6&ndash;153 months); there was one tumor-related death. PFS at 5 and 10 years was 67% and 53%. In multivariate analysis, PFS was significantly prolonged in patients with GTR (HR 0.1; CI 0.03&ndash;0.37; p < 0.001), unmethylated MGMT promoter (HR 0.18; CI 0.05&ndash;0.64; p = 0.009) and midline tumors (HR 0.21; CI 0.06&ndash;0.78; p = 0.02). In conclusion, MGMT promoter methylation status and tumor location were identified as novel prognostic factors in adult PAs, pointing at distinct molecular subtypes and detecting patients in need of close observance and intensified treatment. 
650 4 |a adult 
650 4 |a gross total resection 
650 4 |a MGMT promoter methylation status 
650 4 |a pilocytic astrocytoma 
650 4 |a progression-free survival 
650 4 |a tumor location 
700 1 |a Reinhardt, Annekathrin  |d 1986-  |e VerfasserIn  |0 (DE-588)1078930309  |0 (DE-627)839814488  |0 (DE-576)452072611  |4 aut 
700 1 |a Warta, Rolf  |d 1980-  |e VerfasserIn  |0 (DE-588)1047472260  |0 (DE-627)778430839  |0 (DE-576)401088030  |4 aut 
700 1 |a Capper, David  |d 1979-  |e VerfasserIn  |0 (DE-588)133950751  |0 (DE-627)558829902  |0 (DE-576)300212402  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Herold-Mende, Christel  |e VerfasserIn  |0 (DE-588)1022936549  |0 (DE-627)717335577  |0 (DE-576)366194267  |4 aut 
700 1 |a Unterberg, Andreas  |e VerfasserIn  |0 (DE-588)1032681187  |0 (DE-627)738641200  |0 (DE-576)168441233  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 11(2019,8) Artikel-Nummer 1072, 15 Seiten  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma 
773 1 8 |g volume:11  |g year:2019  |g number:8  |g extent:15  |a Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma 
856 4 0 |u https://doi.org/10.3390/cancers11081072  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/11/8/1072  |x Verlag 
951 |a AR 
992 |a 20191021 
993 |a Article 
994 |a 2019 
998 |g 1032681187  |a Unterberg, Andreas  |m 1032681187:Unterberg, Andreas  |d 910000  |d 911200  |e 910000PU1032681187  |e 911200PU1032681187  |k 0/910000/  |k 1/910000/911200/  |p 7  |y j 
998 |g 1022936549  |a Herold-Mende, Christel  |m 1022936549:Herold-Mende, Christel  |d 910000  |d 911200  |e 910000PH1022936549  |e 911200PH1022936549  |k 0/910000/  |k 1/910000/911200/  |p 6 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 133950751  |a Capper, David  |m 133950751:Capper, David  |p 4 
998 |g 1047472260  |a Warta, Rolf  |m 1047472260:Warta, Rolf  |d 910000  |d 911200  |e 910000PW1047472260  |e 911200PW1047472260  |k 0/910000/  |k 1/910000/911200/  |p 3 
998 |g 1078930309  |a Reinhardt, Annekathrin  |m 1078930309:Reinhardt, Annekathrin  |d 910000  |d 912000  |e 910000PR1078930309  |e 912000PR1078930309  |k 0/910000/  |k 1/910000/912000/  |p 2 
998 |g 1051888247  |a Jungk, Christine  |m 1051888247:Jungk, Christine  |d 50000  |e 50000PJ1051888247  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1679171925  |e 3525690142 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"29 July 2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Christine","roleDisplay":"VerfasserIn","role":"aut","display":"Jungk, Christine","family":"Jungk"},{"family":"Reinhardt","display":"Reinhardt, Annekathrin","roleDisplay":"VerfasserIn","given":"Annekathrin","role":"aut"},{"display":"Warta, Rolf","family":"Warta","role":"aut","roleDisplay":"VerfasserIn","given":"Rolf"},{"family":"Capper","display":"Capper, David","roleDisplay":"VerfasserIn","given":"David","role":"aut"},{"family":"Deimling","display":"Deimling, Andreas von","roleDisplay":"VerfasserIn","given":"Andreas von","role":"aut"},{"display":"Herold-Mende, Christel","family":"Herold-Mende","role":"aut","roleDisplay":"VerfasserIn","given":"Christel"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Andreas","display":"Unterberg, Andreas","family":"Unterberg"}],"title":[{"title_sort":"Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma","title":"Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytoma"}],"physDesc":[{"extent":"15 S."}],"id":{"eki":["1679171925"],"doi":["10.3390/cancers11081072"]},"note":["Gesehen am 21.10.2019"],"language":["eng"],"recId":"1679171925","name":{"displayForm":["Christine Jungk, Annekathrin Reinhardt, Rolf Warta, David Capper, Andreas von Deimling, Christel Herold-Mende and Andreas Unterberg"]},"relHost":[{"part":{"extent":"15","volume":"11","year":"2019","text":"11(2019,8) Artikel-Nummer 1072, 15 Seiten","issue":"8"},"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"language":["eng"],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisher":"MDPI"}],"title":[{"title":"Cancers","title_sort":"Cancers"}],"pubHistory":["1.2009 -"],"note":["Gesehen am 27.05.2020"],"id":{"eki":["614095670"],"zdb":["2527080-1"],"issn":["2072-6694"]},"recId":"614095670","disp":"Extent of resection, MGMT promoter methylation status and tumor location independently predict progression-free survival in adult sporadic pilocytic astrocytomaCancers","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a JUNGKCHRISEXTENTOFRE2920